Yan Nie

Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Next-generation smart ophthalmic biomaterials: From passive response to active interaction and closed-loop control.

Next-generation smart ophthalmic biomaterials: From passive response to active interaction and closed-loop control.

Journal: Bioactive materials
Published: September 08, 2025

Interleukin-27 is a multitarget regulator of fibroblast remodeling in thyroid-associated ophthalmopathy.

Interleukin-27 is a multitarget regulator of fibroblast remodeling in thyroid-associated ophthalmopathy.

Journal: iScience
Published: July 23, 2025

Thyroid hormone signaling in ocular development and diseases.

Thyroid hormone signaling in ocular development and diseases.

Journal: Biological research
Published: April 07, 2025

Refraction difference value variations in children and adolescents with different refractive errors.

Refraction difference value variations in children and adolescents with different refractive errors.

Journal: International journal of ophthalmology
Published: April 04, 2024

An artificial intelligence platform for the screening and managing of strabismus.

An artificial intelligence platform for the screening and managing of strabismus.

Journal: Eye (London, England)
Published: December 04, 2023

TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway.

TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway.

Journal: Translational oncology
Published: July 14, 2023

Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.

Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.

Journal: Frontiers in pharmacology
Published: May 23, 2023

Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.

Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.

Journal: BMC cancer
Published: September 06, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026